China Medical System Gets Acceptance From China's NMPA For New Drug Application Of Ruxolitinib Phosphate Cream For Treatment Of Atopic Dermatitis - TradingView

2026-02-24 - 10:53

China Medical System Gets Acceptance From China's NMPA For New Drug Application Of Ruxolitinib Phosphate Cream For Treatment Of Atopic Dermatitis TradingView